| Group of interest | Count | % | Sample type | Count | % | Age | Count | % | In-vitro/Ex-vivo | Count | % | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sepsis | 25 | 48.07692308 | Whole Blood | 32 | 61.53846154 | Adult | 39 | 75 | Ex-vivo | 39 | 75 | |||
| Septic shock | 10 | 19.23076923 | PBMCs | 7 | 13.46153846 | Neonate | 2 | 3.846153846 | In-vitro | 13 | 25 | |||
| LPS exposure | 7 | 13.46153846 | Neutrophils | 5 | 9.615384615 | Pediatric | 11 | 21.15384615 | ||||||
| S. aureus infection | 3 | 5.769230769 | Cardiac tissue | 1 | 1.923076923 | |||||||||
| Bacterial infection | 2 | 3.846153846 | Induced sputum | 1 | 1.923076923 | |||||||||
| SIRS | 1 | 1.923076923 | Monocytes | 3 | 5.769230769 | |||||||||
| Blood infection | 1 | 1.923076923 | Whole Blood, lymphocytes, monocytes | 1 | 1.923076923 | |||||||||
| E. coli exposure | 1 | 1.923076923 | Dendritic cells | 1 | 1.923076923 | |||||||||
| Systemic Inflammation | 1 | 1.923076923 | THP-1 | 1 | 1.923076923 | |||||||||
| Clarkson's Disease | 1 | 1.923076923 |
